ACE2 and COVID-19: Bachtiar et al. (2024) evaluated the association between dysbiotic periopathogens and inflammatory initiators and mediators in patients with COVID-19 and diabetes, and observed that patients with periodontitis, T2DM, and COVID-19 had a positive correlation (p < 0.05) between ACE-2 expression and inflammatory markers [265].